Delivery Order SPE2DB20D3303-SPE2DB23FZ6D9
Award Date
5/18/23
Potential Completion Date
5/19/23
Potential Value
$11K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $8,963.70 firm fixed-price delivery order is for the pharmaceutical product Cosentyx 300 mg dose. The contract has an ultimate completion date of May 16, 2023. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $19,651.29 firm-fixed-price delivery order is for Cosentyx 300 mg dose-2 pens. The order has an ultimate completion date of April 14, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a comprehensive range of...
This federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical was issued to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., to deliver Cosentyx 300 mg doses in syringes. The firm-fixed-price delivery order, valued at $26,746.11, has an ultimate completion date of December 20, 2023. This award is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA, valued at up to $999,999,999.00, which serves as the primary vehicle for the...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $22,303.00 for the pharmaceutical product Cosentyx Sensiready 300mg Dose-2penmL. The award was made by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense, and has an ultimate completion date of October 12, 2023. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
This federal contract award, valued at $19,250.14, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of the pharmaceutical product Cosentyx 300 mg dose-2 pen. It is a firm fixed-price delivery order contract with a completion date of May 2, 2023. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $5,972.52 for the pharmaceutical product COSENTYX 300 MG DOSE-2 PENSML. The award was made by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of April 4, 2022. The contract is a firm fixed-price delivery order with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999...
This federal contract award to Amerisourcebergen Drug Corporation's Corporate Office Division is for the supply of the pharmaceutical product Cosentyx (300mg dose) to the U.S. government. The single-award Indefinite Delivery Contract (IDC) is with the Defense Logistics Agency (DLA) Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. This contract serves as the primary vehicle for Amerisourcebergen to provide a wide range of pharmaceutical products and medical...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., involves the delivery of Cosentyx 300 mg injectable medication. The $7,465.65 Firm Fixed Price contract was awarded by the Defense Logistics Agency (DLA) on May 26, 2022, with a completion date of May 27, 2022. The contract is a Delivery Order and does not have a set-aside designation, indicating open competition. Amerisourcebergen, a major pharmaceutical distributor, holds a $999,999,999 Indefinite...
This federal contract award is for the delivery of Cosentyx 300 mg dose-2 pen SML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $7,807.59 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on April 25, 2022. The contract has an ultimate completion date of April 26, 2022 and was not designated under any set-aside program. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds...
The U.S. Defense Logistics Agency (DLA) awarded a $6,293.00 Firm Fixed Price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division to supply the pharmaceutical product Cosentyx SNRDY 300MG DOSE-2PENML. This order is part of Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. Under this single-award IDC, Amerisourcebergen provides a comprehensive range of pharmaceutical...